Skip to main content

Table 2 Clinical Characteristics and presence of comorbidities

From: Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

Clinical characteristics

Family history of diabetes (N, %; Yes)

555 (48.6)

T2DM duration

 0–6 months

109 (9.6)

 6 months to 5 years

351 (30.8)

 6–10 years

217 (19.0)

  ≥ 10 years

464 (40.7)

Dyslipidemia (N, %; Yes)

702 (61.5)

Hypertension (N, %; Yes)

682 (59.8)

Treatment modality (N, %)

 Diet and exercise

58 (5.1)

 Oral antidiabetic agents only

773 (67.7)

 Injectable antidiabetic agents only

131 (11.5)

 Combination of oral and injectable antidiabetic agents

180 (15.8)

No. of antidiabetic agents used (N, %)

 1

719 (66.3)

 2

279 (25.7)

  ≥ 3

86 (7.9)

Hyperthyroid (N, %; Yes)

21 (1.8)

Hypothyroid (N, %; Yes)

182 (16.0)

Coronary artery disease (N, %; Yes)

247 (21.6)

Heart failure (N, %; Yes)

94 (8.2)

Atrial fibrillation (N, %; Yes)

94 (8.2)

Stroke (N, %; Yes)

53 (4.6)

Transient ischemic attach (N, %; Yes)

50 (4.4)

Peripheral arterial disease (N, %; Yes)

73 (6.4)

Peripheral neuropathy (N, %; Yes)

74 (6.5)

Erectile dysfunction (N, %; Yes)

6 (0.5)

Diabetic foot (N, %; Yes)

25 (2.2)

Retinopathy (N, %; Yes)

57 (5)

eGFRa (Mean ± SD; ml/min/1.73m2)

67.70 ± 17.05

  1. CKD chronic kidney disease, eGFR estimated glomerular filtration rate, T2DM type 2 diabetes mellitus
  2. aEstimated using CKD-EPI equation